Adherium Ltd. · ASX:ADR
Adherium — AusBiotech 2016
4 slides from Adherium's conference presentation, Oct 26, 2016
Slide 1: Adherium AusBiotech Presentation, 26 October 2016
Adherium® AusBiotech Presentation 26 October 2016
Slide 2: Investment Highlights
INVESTMENT HIGHLIGHTS Adherium provides valuable exposure to the rapidly growing digital health sector Commercialisation stage digital health company with a clear path to profitability Valuable intellectual property portfolio, with a 15 year investment in one of the world’s largest databases of
Slide 3: Positioning Adherium for Commercialisation
POSITIONING ADHERIUM FOR COMMERCIALISATION Adherium is now well positioned for rapid commercialisation and growth Future milestones Negotiate and sign agreement with leading global distributor partner Payor/provider roll-out Sign full contract with US hospital network and fully integrate SmartIn
Slide 4: Disclaimer and Forward Looking Statements
DISCLAIMER AND FORWARD LOOKING STATEMENTS The following material is of a general nature and has only been prepared as a presentation aid. This presentation does NOT contain all of the information that may be required for evaluating Adherium Limited ACN 605 352 510 (Adherium® ), its assets, prospects